Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates. - Wikidata - awgldk - TriplyDB

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

http://www.wikidata.org/entity/Q41910884

about

Polymer-drug conjugates: origins, progress to date and future directions Macromolecular therapeutics Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cells Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy POLYMERIC BIOMATERIALS AND NANOMEDICINES.Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma.Role of polymer-drug conjugates in organ-specific delivery systems.Chemical Protein Modification through Cysteine.Synthesis of maleimide-functionalyzed HPMA-copolymers and in vitro characterization of the aRAGE- and human immunoglobulin (huIgG)-polymer conjugates.Design of smart HPMA copolymer-based nanomedicines.DNA-scaffolded multivalent ligands to modulate cell function.Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.Stimuli Responsive Polymeric Systems for Cancer Therapy

P2860

Q27002505-21D528C9-D381-452E-973D-C03DF8E3EF41 Q34079574-8DF74C9E-E346-457A-A1FC-C78579B89490 Q34855819-E937FE13-1590-4D00-AA92-ED77762F9D3A Q35611416-0637BAA3-4F00-48A7-8B08-A89C478B1EC4 Q35633346-0DDE7535-7768-480A-91B0-1618C18B7F5B Q35861726-9C4479DE-7292-4860-8455-870D5BC019CA Q36126612-EACA3E57-7296-4D3F-AAD3-0436A55338E6 Q36376467-04BA0224-5158-45F6-BA46-B741436ECAD7 Q36611125-94DAC8F8-4BDC-482B-8C1B-6DDB3136BCA4 Q37537969-2689AFF3-CA3F-4AC0-AC83-1C10F56B6293 Q38253121-D29AFE4C-9692-4F34-B2B0-B4AD2CF52B4E Q38365556-42AA48F8-38C0-483B-AA61-DBAEE15B00D0 Q38704033-08DF5934-799E-4452-819A-5A4A9FE585DC Q39226207-359204EE-6971-435F-A1E2-CAB77EF34B19 Q42553783-277FD4E9-24F7-4AA8-9FA0-46C952AAACAF Q46196202-914AC4DE-D224-4A1A-A24A-81AA4C16CCA0 Q53609318-DAF81332-C189-4EED-8A20-A759F569FB65 Q55052715-271CA7A1-B066-44CF-89C5-4DACD57DCED5 Q57328205-7894BD14-14F8-405D-8C7E-9A0B80C82A35

P2860

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

http://www.wikidata.org/entity/Q41910884

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

@en

type

label

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

@en

prefLabel

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

@en

P1433

Q41910884-25C3B862-0F6D-4214-9E97-8B16C80917B5

P1476

Q41910884-3A6FB382-024F-409B-BC9D-696136442528

P2093

Q41910884-40035EC0-017D-40C9-94E5-0DBA8DA2A19D

Q41910884-84E0F40D-F45D-4543-9D22-46FA59DCAA05

Q41910884-FCFE9F45-DDA5-4AAD-BC50-CDD9F81B8A77

P2860

Q41910884-01355948-806C-41E6-AD67-AD1659303E30

Q41910884-0B04926D-CF14-4BFE-BD07-D8FC6020B07E

Q41910884-111E0799-050A-4A4E-86D4-7D86EDDB1A7D

Q41910884-12486A5B-7C01-43BD-B803-BA7C6FA31DA8

Q41910884-2595891E-BB69-416B-BC2F-0AA6DE41C9CB

Q41910884-26CAF069-B465-48E0-945D-E883BD5FA3C6

Q41910884-3165F4C2-B7D3-46D1-8E33-CCFE93B30F86

Q41910884-348E4FFD-CE45-4B9F-9151-73A8F53692FB

Q41910884-3BC72224-7AD9-4F1D-A133-87FE4E742CF4

Q41910884-545774E3-9FB4-427A-9318-26E0DA0D236E

P304

Q41910884-BD741DA1-4163-475F-805D-D5D7AE75F726

P31

Q41910884-D791D561-E664-49FE-8279-EF5423426F31

P356

Q41910884-95BD97AA-D62C-44FC-8348-7E8C4ED212D0

P433

Q41910884-9ED0DA5C-9129-46F8-AE07-EE62796D8E2B

P478

Q41910884-83058538-F0F9-4CC6-88BF-66F0B097DF4B

P577

Q41910884-3FC456EE-0DB9-4938-85BA-275967547905

P5875

Q41910884-48136E42-1CA8-4357-86DF-2C39D708606E

P698

Q41910884-6F1F288E-3483-4229-AC92-367048B9CC2C

P932

Q41910884-16488CE6-04A1-43B9-9BA7-708606CA97F6

P356

P1433

Biomacromolecules

P1476

Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

@en

P2093

Jindřich Kopeček

http://www.w3.org/2001/XMLSchema#string

Pavla Kopečková

http://www.w3.org/2001/XMLSchema#string

Russell N Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains

Direct demonstration that receptor crosslinking or aggregation is important in insulin action

Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes

Nanotechnology: intelligent design to treat complex disease

Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice.

Single-cell cytotoxicity with radiolabeled antibodies.

HPMA copolymers: origins, early developments, present, and future.

Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.

Synthetic multivalent ligands in the exploration of cell-surface interactions.

Quantifying aggregation of IgE-FcepsilonRI by multivalent antigen

P304

727-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BM201656K

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221790385

http://www.w3.org/2001/XMLSchema#string

P698

22288884

http://www.w3.org/2001/XMLSchema#string

P932

3299848

http://www.w3.org/2001/XMLSchema#string